PubMed · 2006 · 12 citations · 0 references
Open access
MedicinePharmacologyPharmacotherapyClinical PharmacologyGastroenterologyGastrointestinal PharmacotherapyEsophageal DiseasesGastroesophageal Reflux DiseaseGastroesophageal Reflux Disease CareGastrointestinal PharmacologyHeartburn ManagementGastroesophageal Reflux Disease PharmacotherapyGerd Symptom AssessmentPharmacologic Therapy For GerdReflux EsophagitisSingle-blind Trials
The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to healing and relief from gastroesophageal reflux disease-related symptoms. I this multicentre, randomized, single-blind study 180 patients (ITT population) diagnosed with endoscopically proven GERD grade A,B,C received esomeprazole (40 mg once daily (o.d.), n = 90) orpantoprazole (40 mg o.d., n = 90). Healing and relief from GERD-related symptoms were assessed at first and final visit (after 4 or 8 weeks of treatment). Esomeprazole 40 mg provided significantly greater healing than pantoprazole 40 mg after 4 weeks of treatment in patients with EE (77.8% vs. 72.2%). Esomeprazole-treated patients were healed after up to 8 weeks of treatment similar those treated with pantoprazole (92.2% vs. 91.1%). The proportion of heartburn-free days was similar in patients treated with esomeprazole and to those treated with pantoprazole.